HEALTH CARE UTILIZATION (HCU) BY BREAST CANCER (BC) AND NON-HODGKIN LYMPHOMA (NHL) PATIENTS WITH CHEMOTHERAPY INDUCED FEBRILE NEUTROPENIA (FN) IN THE NETHERLANDS

被引：0
|
作者：
Issa, D. E. [1 ]
van Herk-Sukel, M. P. P. [2 ]
Gelderblom, H. [3 ]
Houweling, L. M. A. [2 ]
Jager, A. [4 ]
De La Orden, M. [5 ]
Lugtenburg, P. J. [4 ]
van der Werf-Langenberg, M. E. [6 ]
Nortier, J. W. R. [3 ]
de Jong, F. A. [6 ]
机构：
[1] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands
[2] PHARMO Inst, Utrecht, Netherlands
[3] Leiden Univ Med Ctr, Leiden, Netherlands
[4] Erasmus MC, Rotterdam, Netherlands
[5] Amgen Inc, Uxbridge, Middx, England
[6] Amgen BV, Breda, Netherlands
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A435 / A435
页数：1
相关论文
共 50 条
  • [1] Health Care Utilization (HCU) by Breast Cancer (BC) and Non-Hodgkin Lymphoma (NHL) Patients (pts) with Chemotherapy (CT) Induced Febrile Neutropenia (FN) in the Netherlands
    Gelderblom, Hans
    Lugtenburg, Pieternella J.
    Nortier, Hans W. R.
    Van Herk-Sukel, Myrthe P.
    Issa, Djamila E.
    Jager, Agnes
    De la Orden, Margarita
    Van der Werf-Langenberg, Mirte E.
    Houweling, Leanne M. A.
    De Jong, Floris A.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 465 - 466
  • [2] Health care utilization (HCU) by breast cancer (BC) and non-Hodgkin lymphoma (NHL) patients (pts) with chemotherapy (CT) induced febrile neutropenia (FN) in the Netherlands
    Gelderblom, Hans
    Lugtenburg, Pieternella
    Nortier, J. W. R.
    van Herk-Sukel, Myrthe
    Issa, Djamila
    Jager, A.
    De La Orden, Margarita
    van der Werf-Langenberg, Mirte
    Houweling, Leanne
    De Jong, Floris Aart
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [3] INPATIENT HOSPITAL COSTS OF FEBRILE NEUTROPENIA (FN) AS A CONSEQUENCE OF CHEMOTHERAPY (CHT) FOR BREAST CANCER (BC) AND NON-HODGKIN LYMPHOMA (NHL) IN SWITZERLAND
    Mattli, R.
    Pletscher, M.
    Eichler, K.
    Wieser, S.
    VALUE IN HEALTH, 2013, 16 (07) : A405 - A405
  • [4] Chronic Comorbidities and Chemotherapy-Induced Febrile Neutropenia in Patients with Non-Hodgkin Lymphoma
    Chao, Chun
    Page, John H.
    Rodriguez, Roberto
    Yang, Su-Jau
    Huynh, Julie
    Chia, Victoria M.
    BLOOD, 2012, 120 (21)
  • [5] Febrile neutropenia and mortality in patients with breast cancer, lung cancer, and non-Hodgkin lymphoma.
    Kawatkar, Aniket A.
    Chao, Chun
    Chen, Wansu
    Barron, Richard L.
    Xu, Hairong
    Reiner, Maureen
    Vogl, Florian D.
    Chandler, David
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [6] Use of supportive care and risk of febrile neutropenia (FN) among patients receiving myelosuppressive chemotherapy for solid tumors or non-Hodgkin's lymphoma (NHL) at four US health systems.
    Weycker, Derek
    Silvia, Amanda
    Shyta, Erinda
    Richert-Boe, Kathryn E.
    Bensink, Mark
    Lamerato, Lois E.
    Kaur, Manpreet
    Rooney, James J.
    Chandler, David
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [7] Prophylaxis of chemotherapy-induced neutropenia and febrile neutropenia with lipegfilgrastim in patients with non-Hodgkin lymphoma (NADIR study)
    Wolff, Thomas
    Schulz, Holger
    Losem, Christoph
    Reichert, Dietmar
    Hurtz, Hans-Juergen
    Sandner, Reiner
    Harde, Johanna
    Grebhardt, Sina
    Potthoff, Karin
    Mueller, Udo
    Fietz, Thomas
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2019, 102 (02) : 174 - 181
  • [8] Risk of chemotherapy-induced febrile neutropenia (FN) in patients (pts) with non-metastatic breast cancer (BC) and documented risk factors for FN
    Weycker, Derek
    Li, Xiaoyan
    Barron, Richard
    Wu, Hongsheng
    Morrow, Phuong Khanh
    Xu, Hairong
    Reiner, Maureen
    Garcia, Jacob
    Mhatre, Shivani
    Lyman, Gary
    CANCER RESEARCH, 2015, 75
  • [9] Febrile neutropenia-related care and associated costs in elderly patients with breast cancer, lung cancer, or non-Hodgkin lymphoma
    Shuling Li
    Jiannong Liu
    Charles Bowers
    Tamer A. F. S. Garawin
    Christopher Kim
    Mark E. Bensink
    David B. Chandler
    Supportive Care in Cancer, 2020, 28 : 113 - 122
  • [10] Febrile neutropenia-related care and associated costs in elderly patients with breast cancer, lung cancer, or non-Hodgkin lymphoma
    Li, Shuling
    Liu, Jiannong
    Bowers, Charles
    Garawin, Tamer A. F. S.
    Kim, Christopher
    Bensink, Mark E.
    Chandler, David B.
    SUPPORTIVE CARE IN CANCER, 2020, 28 (01) : 113 - 122
12345